Bertrand Sauneuf, Jennifer Brunet, Olivier Lucidarme, Damien du Cheyron
{"title":"Prevalence and risk factors of vitamin D deficiency in critically ill patients.","authors":"Bertrand Sauneuf, Jennifer Brunet, Olivier Lucidarme, Damien du Cheyron","doi":"10.2174/18715281113129990045","DOIUrl":null,"url":null,"abstract":"<p><p>Vitamin D (Vit D) is well known for its traditional role in calcium and bone homeostasis. Sun exposure and diet are essential for Vit D synthesis and intake. However, the association of Vit D deficiency with various diseases has held the attention of clinicians. Of note, Vit D has pleiotropic effects that could be involved in the optimal functioning of many organ systems. Several epidemiologic studies have documented widespread Vit D deficiency worldwide. Vit D deficiency is also frequent in hospitalized patients. Recently, publications have suggested a high prevalence of Vit D deficiency in critically ill patients, which might have a clinical impact in this specific population. However, few studies have specifically investigated the prevalence and risk factors of Vit D deficiency in intensive care units. The available data indicate a Vit D deficiency prevalence of 80% to 100% in critically ill patients. The risk factors associated with Vit D deficiency include variables dependent on demographic characteristics, such as ethnicity, age and sex, lifestyle and diet, medical history and medications, and acute critical illness. Of note, the presence of a systemic inflammatory response and the severity of acute illness may affect the Vit D status. This review presents the current knowledge on the prevalence of Vit D deficiency in the critically ill and the associated risk factors. </p>","PeriodicalId":13680,"journal":{"name":"Inflammation & allergy drug targets","volume":"12 4","pages":"223-9"},"PeriodicalIF":0.0000,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammation & allergy drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/18715281113129990045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14
Abstract
Vitamin D (Vit D) is well known for its traditional role in calcium and bone homeostasis. Sun exposure and diet are essential for Vit D synthesis and intake. However, the association of Vit D deficiency with various diseases has held the attention of clinicians. Of note, Vit D has pleiotropic effects that could be involved in the optimal functioning of many organ systems. Several epidemiologic studies have documented widespread Vit D deficiency worldwide. Vit D deficiency is also frequent in hospitalized patients. Recently, publications have suggested a high prevalence of Vit D deficiency in critically ill patients, which might have a clinical impact in this specific population. However, few studies have specifically investigated the prevalence and risk factors of Vit D deficiency in intensive care units. The available data indicate a Vit D deficiency prevalence of 80% to 100% in critically ill patients. The risk factors associated with Vit D deficiency include variables dependent on demographic characteristics, such as ethnicity, age and sex, lifestyle and diet, medical history and medications, and acute critical illness. Of note, the presence of a systemic inflammatory response and the severity of acute illness may affect the Vit D status. This review presents the current knowledge on the prevalence of Vit D deficiency in the critically ill and the associated risk factors.